Responses
Oral Poster – TAPED
Oral Featured Posters – Pre-Recorded
IGCS20_1102
36 Prognostic value and association with veliparib benefit of modeled CA-125 elimination kinetics (KELIM) in patients with newly diagnosed ovarian cancer: analysis from the VELIA/GOG-3005 study
Compose a Response to This Article
Other responses
No responses have been published for this article.